This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Celator Pharmaceuticals, Inc.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Steven M Ansell: Innovator in Taxane Delivery Systems
Introduction
Steven M Ansell is a notable inventor based in Princeton, NJ (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the delivery of taxane conjugate prodrugs. His innovative work has the potential to enhance the efficacy of cancer treatments.
Latest Patents
Steven M Ansell holds 1 patent for his invention titled "Taxane delivery system." This patent describes nanoparticulate formulations designed for the delivery of taxane conjugate prodrugs. The formulations involve a taxane coupled to a hydrophobic moiety through a glycolate linker, showcasing a novel approach to drug delivery.
Career Highlights
Ansell is currently associated with Celator Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work at Celator Pharmaceuticals focuses on innovative solutions for cancer treatment, contributing to the company's mission of improving patient outcomes.
Collaborations
Throughout his career, Steven has collaborated with talented professionals, including Sharon Johnstone and Paul Tardi. These collaborations have fostered a dynamic environment for innovation and have led to advancements in pharmaceutical technologies.
Conclusion
Steven M Ansell's contributions to the field of drug delivery systems exemplify the impact of innovative thinking in pharmaceuticals. His work not only enhances treatment options but also paves the way for future advancements in cancer therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile